You are now leaving XTANDI.com
The website you are about to visit is not owned or controlled by Astellas. Astellas are not responsible for the information or services on this site.
NORTHBROOK, Ill., August 2, 2017 – Astellas today announced three senior-level changes in its Corporate Affairs organization, and several promotions throughout the function. Moyra Knight is promoted to Executive Director, Communications and Corporate Citizenship; Karl Uhlendorf is promoted to Senior Director, Policy and Government Communications; and Andrew Lewis is promoted to Senior Director, Medical and Development Communications. Knight and Lewis will report to Senior Vice President Corporate Affairs Jeffrey A. Winton while Uhlendorf will report to Vice President of Policy and Government Affairs Joseph Devaney.
Knight, who oversees corporate communications, employee engagement and sustainability efforts for Astellas in the Americas, will add Business Communications, charitable giving as well as Canada and Latin America regional communications. She will continue to serve as the President of the Astellas USA Foundation.
Uhlendorf will assume responsibility for the Astellas Political Action Committee (PAC), Executive Communications as well as policy and government affairs communications based out of Astellas’ Washington, D.C. offices.
Lewis will expand Astellas’ Medical and Development Communications with responsibility for the Astellas Institute of Regenerative Medicine (AIRM) in Marlborough, Mass. and the Astellas Research Institute of America (ARIA) in San Diego, Calif. He will oversee communications support for Astellas’ Medical and Development team in EMEA and Asia Oceania in addition to the Americas. Lewis established a new communications organization for Astellas’ Medical and Development in 2014.
"We began building this new capability within Astellas nearly four years ago, and during this time, the company has experienced tremendous growth," says Winton. "At the same time, our industry continues to go through unprecedented change, and so the evolution of the Corporate Affairs function will now reflect these dynamics both internally and in the marketplace."
Additional transitions in the Corporate Affairs function include:
About Astellas
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at http://www.astellas.us/. You can also follow us on Twitter at @AstellasUS, Facebook at http://www.facebook.com/AstellasUS or LinkedIn at www.linkedin.com/company/astellas-pharma.
Get only the email alerts you want.
For media inquiries and reporter requests, please email us at corporate.communications@us.astellas.com.
Our communications team will respond to verified media requests within 24-48 hours as appropriate.
If you are not a reporter and need assistance, please visit our contact us page that includes information for patients, healthcare providers and researchers.
This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.
The site uses cookies to provide you with a more responsive and personalized service and to analyze site traffic. By using this site, you accept our use of cookies as described in our privacy policy. Please read our privacy policy for more information on the cookies we use, the processing of your personal data and how to delete or block the use of cookies.